Graham Edmund Kelly

Founder chez NYRADA INC. Fortune : 2 M $ au 31/03/2024

Profil

Graham Edmund Kelly was the founder of Kazia Therapeutics Ltd.
(founded in 1994) where he held the title of Executive Chairman & Chief Executive Officer from 2013 to 2015.
He was also the founder of MEI Pharma, Inc. (founded in 2001) where he served as a Non-Executive Director from 2001 to 2006.
Additionally, he founded Noxopharm Ltd.
(founded in 2015) and Nyrada, Inc. (founded in 2017) where he holds the title of Non-Executive Director and President & Director respectively.
Dr. Kelly's former job includes being the Executive Chairman of Triaxial Pharmaceuticals Pty Ltd.
from 2011 to 2012.
He obtained his undergraduate degree from The University of Sydney in 1968 and his doctorate degree from the same institution in 1972.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
NOXOPHARM LTD. 12,34%	20/09/2022	36 052 294 ( 12,34% )	2 M $	31/03/2024

Postes actifs de Graham Edmund Kelly

Sociétés	Poste	Début
NYRADA INC.	Founder	29/08/2017

Anciens postes connus de Graham Edmund Kelly

Sociétés	Poste	Fin
NOXOPHARM LIMITED	Chief Executive Officer	01/02/2022
KAZIA THERAPEUTICS LIMITED	Chief Executive Officer	21/07/2015
Triaxial Pharmaceuticals Pty Ltd.	Chairman	01/12/2012
MEI PHARMA, INC.	Founder	01/01/2006

Formation de Graham Edmund Kelly

The University of Sydney

Undergraduate Degree